Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Eide

Showing results (51-60 of 116) with videos related to

Pageof 12
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 28, 2015
Plasma levels of marine n-3 polyunsaturated fatty acids and renal allograft survivalIvar A Eide, Trond Jenssen, Anders Hartmann, et al.
Cancer Cell|July 9, 2010
Wnt/Ca2+/NFAT signaling maintains survival of Ph+ leukemia cells upon inhibition of Bcr-AblMark A Gregory, Tzu L Phang, Paolo Neviani, et al.
Clinical Transplantation|August 16, 2014
Uric acid and clinical correlates of endothelial function in kidney transplant recipientsDag Olav Dahle, Trond Jenssen, Hallvard Holdaas, et al.
European Journal of Clinical Nutrition|March 3, 2016
Plasma levels of marine n-3 fatty acids and cardiovascular risk markers in renal transplant recipientsI A Eide, D O Dahle, M Svensson, et al.
Blood Advances|January 25, 2022
Associating drug sensitivity with differentiation status identifies effective combinations for acute myeloid leukemiaStephen E Kurtz, Christopher A Eide, Andy Kaempf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 18, 2014
Antagonism of SET using OP449 enhances the efficacy of tyrosine kinase inhibitors and overcomes drug resistance in myeloid leukemiaAnupriya Agarwal, Ryan J MacKenzie, Raffaella Pippa, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 13, 2013
Foretinib is a potent inhibitor of oncogenic ROS1 fusion proteinsMonika A Davare, Anna Saborowski, Christopher A Eide, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|November 14, 2016
Plasma Levels of Marine n-3 Fatty Acids Are Inversely Correlated With Proinflammatory Markers sTNFR1 and IL-6 in Renal Transplant RecipientsIvar A Eide, Anders Åsberg, My Svensson, et al.
Leukemia|February 26, 2020
Simultaneous kinase inhibition with ibrutinib and BCL2 inhibition with venetoclax offers a therapeutic strategy for acute myeloid leukemiaChristopher A Eide, Stephen E Kurtz, Andy Kaempf, et al.
Science Translational Medicine|September 2, 2016
Targeting BCL-2 and ABL/LYN in Philadelphia chromosome-positive acute lymphoblastic leukemiaJessica T Leonard, Joelle S J Rowley, Christopher A Eide, et al.
Pageof 12

Showing results (51-60 of 116) with videos related to

Sort By:
Pageof 12
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 28, 2015
Plasma levels of marine n-3 polyunsaturated fatty acids and renal allograft survivalIvar A Eide, Trond Jenssen, Anders Hartmann, et al.
Cancer Cell|July 9, 2010
Wnt/Ca2+/NFAT signaling maintains survival of Ph+ leukemia cells upon inhibition of Bcr-AblMark A Gregory, Tzu L Phang, Paolo Neviani, et al.
Clinical Transplantation|August 16, 2014
Uric acid and clinical correlates of endothelial function in kidney transplant recipientsDag Olav Dahle, Trond Jenssen, Hallvard Holdaas, et al.
European Journal of Clinical Nutrition|March 3, 2016
Plasma levels of marine n-3 fatty acids and cardiovascular risk markers in renal transplant recipientsI A Eide, D O Dahle, M Svensson, et al.
Blood Advances|January 25, 2022
Associating drug sensitivity with differentiation status identifies effective combinations for acute myeloid leukemiaStephen E Kurtz, Christopher A Eide, Andy Kaempf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 18, 2014
Antagonism of SET using OP449 enhances the efficacy of tyrosine kinase inhibitors and overcomes drug resistance in myeloid leukemiaAnupriya Agarwal, Ryan J MacKenzie, Raffaella Pippa, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 13, 2013
Foretinib is a potent inhibitor of oncogenic ROS1 fusion proteinsMonika A Davare, Anna Saborowski, Christopher A Eide, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|November 14, 2016
Plasma Levels of Marine n-3 Fatty Acids Are Inversely Correlated With Proinflammatory Markers sTNFR1 and IL-6 in Renal Transplant RecipientsIvar A Eide, Anders Åsberg, My Svensson, et al.
Leukemia|February 26, 2020
Simultaneous kinase inhibition with ibrutinib and BCL2 inhibition with venetoclax offers a therapeutic strategy for acute myeloid leukemiaChristopher A Eide, Stephen E Kurtz, Andy Kaempf, et al.
Science Translational Medicine|September 2, 2016
Targeting BCL-2 and ABL/LYN in Philadelphia chromosome-positive acute lymphoblastic leukemiaJessica T Leonard, Joelle S J Rowley, Christopher A Eide, et al.
Pageof 12